UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $98.00

Colgate-Palmolive (NYSE:CL) had its price target decreased by investment analysts at UBS Group from $100.00 to $98.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has a “buy” rating on the stock. UBS Group’s price objective would suggest a potential upside of 17.59% from the stock’s current price.

CL has been the subject of several other reports. Jefferies Financial Group boosted their target price on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the stock a “hold” rating in a research report on Monday, February 2nd. Wells Fargo & Company boosted their target price on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research report on Sunday, February 1st. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Rothschild & Co Redburn set a $93.00 price objective on shares of Colgate-Palmolive in a report on Friday, February 13th. Finally, TD Cowen reaffirmed a “hold” rating and set a $85.00 price objective on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $95.50.

Colgate-Palmolive Stock Down 1.4%

CL stock traded down $1.19 during trading hours on Tuesday, hitting $83.34. The company’s stock had a trading volume of 2,500,483 shares, compared to its average volume of 6,949,671. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. The company has a market capitalization of $66.87 billion, a PE ratio of 31.79, a price-to-earnings-growth ratio of 3.91 and a beta of 0.34. Colgate-Palmolive has a 12 month low of $74.54 and a 12 month high of $99.33. The stock has a 50 day moving average price of $91.08 and a two-hundred day moving average price of $83.49.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 EPS for the quarter, topping the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.91 earnings per share. On average, equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Insider Activity at Colgate-Palmolive

In related news, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $94.25, for a total transaction of $1,978,213.25. Following the completion of the transaction, the insider directly owned 17,645 shares in the company, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the transaction, the chief financial officer owned 55,310 shares of the company’s stock, valued at approximately $5,214,073.70. The trade was a 63.89% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 184,683 shares of company stock valued at $17,486,693 in the last 90 days. 0.34% of the stock is owned by company insiders.

Hedge Funds Weigh In On Colgate-Palmolive

A number of hedge funds have recently made changes to their positions in the business. Cornerstone Planning LLC acquired a new position in shares of Colgate-Palmolive in the 4th quarter valued at $1,442,000. Rockefeller Capital Management L.P. raised its stake in shares of Colgate-Palmolive by 6.1% in the 4th quarter. Rockefeller Capital Management L.P. now owns 182,223 shares of the company’s stock valued at $14,399,000 after buying an additional 10,512 shares in the last quarter. World Investment Advisors raised its stake in shares of Colgate-Palmolive by 102.4% in the 4th quarter. World Investment Advisors now owns 25,704 shares of the company’s stock valued at $2,031,000 after buying an additional 13,007 shares in the last quarter. Corient Private Wealth LLC raised its stake in shares of Colgate-Palmolive by 13.6% in the 4th quarter. Corient Private Wealth LLC now owns 541,110 shares of the company’s stock valued at $42,789,000 after buying an additional 64,926 shares in the last quarter. Finally, Auto Owners Insurance Co raised its stake in shares of Colgate-Palmolive by 7,802.0% in the 4th quarter. Auto Owners Insurance Co now owns 442,512 shares of the company’s stock valued at $3,497,000 after buying an additional 436,912 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.